REQUEST A DEMO
Total
USD $0.00
Search more companies

Geneplanet d.o.o. (Croatia)

Main Activities: Research and Development in Nanotechnology | Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Geneplanet d.o.o. Profile Updated: August 05, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Geneplanet d.o.o. is an enterprise in Croatia, with the main office in Zagreb. The enterprise currently operates in the Research and Development in Nanotechnology sector. It was established on December 10, 2025. 9 (2024) employees currently work for Geneplanet d.o.o.. The company’s latest financial report indicates a net sales revenue increase of 68.28% in 2024. There was a total growth of 10.29% in Geneplanet d.o.o.’s total assets over the same period. The net profit margin of Geneplanet d.o.o. increased by 4.52% in 2024.

Headquarters
Horvatova 80A Str.
Zagreb; City of Zagreb; Postal Code: 10000

Contact Details: Purchase the Geneplanet d.o.o. report to view the information.

Website: http://www.geneplanet.com

Basic Information
Total Employees:
Purchase the Geneplanet d.o.o. report to view the information.
Financial Auditors:
Purchase the Geneplanet d.o.o. report to view the information.
Incorporation Date:
December 10, 2025
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Geneplanet d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
68.28%
Total operating revenue
68.28%
Operating profit (EBIT)
351.56%
EBITDA
326.65%
Net Profit (Loss) for the Period
4738.85%
Total assets
10.29%
Total equity
211.06%
Operating Profit Margin (ROS)
4.2%
Net Profit Margin
4.52%
Return on Equity (ROE)
63.49%
Debt to Equity Ratio
-912.65%
Quick Ratio
0.23%
Cash Ratio
0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?